Takeda Pharmaceutical Update
Takeda Pharmaceutical has received regulatory approval for its ADCETRIS treatment in Europe.
Company Stock Performance
The company’s stock price has fluctuated within a 52-week range of ¥3852 to ¥4573. The current close price is ¥4288.
Financial Ratios
Technical analysis reveals the following financial ratios:
- Price-to-earnings ratio: 64.31
- Price-to-book ratio: 0.97527